Reactive oxygen species (ROS) are essential components of the innate immune response against intracellular bacteria and it is thought that professional phagocytes generate ROS primarily via the phagosomal NADPH oxidase machinery 1 . However, recent studies have suggested that mitochondrial ROS (mROS) also contribute to mouse macrophage bactericidal activity, although the mechanisms linking innate immune signalling to mitochondria for mROS generation remain unclear 2-4 . Here we demonstrate that engagement of a subset of Toll-like receptors (TLR1, TLR2 and TLR4) results in the recruitment of mitochondria to macrophage phagosomes and augments mROS production. This response involves translocation of a TLR signalling adaptor, tumour necrosis factor receptor-associated factor 6 (TRAF6), to mitochondria, where it engages the protein ECSIT (evolutionarily conserved signalling intermediate in Toll pathways), which is implicated in mitochondrial respiratory chain assembly 5 . Interaction with TRAF6 leads to ECSIT ubiquitination and enrichment at the mitochondrial periphery, resulting in increased mitochondrial and cellular ROS generation. ECSIT-and TRAF6-depleted macrophages have decreased levels of TLR-induced ROS and are significantly impaired in their ability to kill intracellular bacteria. Additionally, reducing macrophage mROS levels by expressing catalase in mitochondria results in defective bacterial killing, confirming the role of mROS in bactericidal activity. These results reveal a novel pathway linking innate immune signalling to mitochondria, implicate mROS as an important component of antibacterial responses and further establish mitochondria as hubs for innate immune signalling.
Reactive oxygen species (ROS) are essential components of the innate immune response against intracellular bacteria and it is thought that professional phagocytes generate ROS primarily via the phagosomal NADPH oxidase machinery 1 . However, recent studies have suggested that mitochondrial ROS (mROS) also contribute to mouse macrophage bactericidal activity, although the mechanisms linking innate immune signalling to mitochondria for mROS generation remain unclear [2] [3] [4] . Here we demonstrate that engagement of a subset of Toll-like receptors (TLR1, TLR2 and TLR4) results in the recruitment of mitochondria to macrophage phagosomes and augments mROS production. This response involves translocation of a TLR signalling adaptor, tumour necrosis factor receptor-associated factor 6 (TRAF6), to mitochondria, where it engages the protein ECSIT (evolutionarily conserved signalling intermediate in Toll pathways), which is implicated in mitochondrial respiratory chain assembly 5 . Interaction with TRAF6 leads to ECSIT ubiquitination and enrichment at the mitochondrial periphery, resulting in increased mitochondrial and cellular ROS generation. ECSIT-and TRAF6-depleted macrophages have decreased levels of TLR-induced ROS and are significantly impaired in their ability to kill intracellular bacteria. Additionally, reducing macrophage mROS levels by expressing catalase in mitochondria results in defective bacterial killing, confirming the role of mROS in bactericidal activity. These results reveal a novel pathway linking innate immune signalling to mitochondria, implicate mROS as an important component of antibacterial responses and further establish mitochondria as hubs for innate immune signalling.
The phagocytic response of the innate immune system involves the production of ROS via the phagosomal NADPH-oxidase-dependent respiratory burst. This is a necessary effector response for the destruction of intracellular microbes 1, 6 . In addition to NADPH-oxidase, the mitochondrial oxidative phosphorylation machinery generates ROS when electrons prematurely escape oxidative phosphorylation complexes I and III and react with molecular oxygen to generate superoxide 7, 8 . Mitochondria are major sites of ROS production in most cells; however, mROS have traditionally been regarded as byproducts of oxidative respiration and therefore their synthesis was believed to be unregulated 7, 9 . To examine whether TLR signalling could enhance mROS production we stimulated RAW 264.7 macrophages (RAW cells) with lipopolysaccharide (LPS, a TLR4 agonist), synthetic lipopeptide Pam3CSK4 (TLR1 and TLR2 agonist), lipotechoic acid (LTA, TLR2 agonist), poly(I:C) (TLR3 agonist), R848 (TLR7 and TLR8 agonist) and CpG DNA (TLR9 agonist) (Fig. 1a ). The production of mROS was triggered only upon signalling from the cell-surface TLRs (TLR1, TLR2 and TLR4), whereas stimulation of endosomal TLRs (TLR3, TLR7, TLR8 and TLR9) failed to augment mROS (Fig. 1a ). Exposure of cells to rotenone and antimycin A, compounds known to increase mitochondrial superoxide generation, did augment mROS but treatment with tumour-necrosis factor-a (TNF-a) did not ( Fig. 1a) 7 . We observed similar increases in mROS when bonemarrow-derived macrophages (BMDMs) were stimulated with TLR1, TLR2 and TLR4 (TLR1/2/4) agonists but we were again unable to detect significant induction of mROS upon ligation of TLR9 ( Fig. 1b ). We also detected increased cellular hydrogen peroxide (H 2 O 2 ) generation upon TLR2/TLR4 ligation, but not after TLR9 ligation ( Fig. 1b) [10] [11] [12] it is not surprising that signalling from cell-surface TLRs, which predominantly recognize ligands derived from bacteria, induces ROS generation 13 . In contrast, ROS are not used as direct antiviral effectors and hence endosomal TLRs, which function primarily in sensing viral infection, do not seem to augment ROS production.
Several reports have indicated that mitochondria are recruited to vacuoles containing intracellular pathogens [14] [15] [16] [17] . To investigate whether recruitment of mitochondria to phagosomes might be an active process mediated by innate immune signalling, we examined mitochondrial localization in cells loaded with latex beads coated with pathogen-associated molecular patterns (PAMPs). Such coated beads have been used previously to investigate signalling in phagocytic cells and have been shown to recruit innate immune signalling components, analogous to phagocytosed bacteria 18, 19 . Interestingly, we observed mitochondrial recruitment and cupping around Pam3CSK4-and LPS-coated beads in BMDMs ( Fig. 1c ). Uncoated beads, despite being taken up by BMDMs to a similar extent, did not co-localize efficiently with mitochondrial networks and displayed markedly lower mitochondrial cupping per bead ( Fig. 1c and Supplementary Fig. 2 ).
On the basis of the above findings, we hypothesized that the inducible juxtaposition of phagosomes and mitochondria should be accompanied by the concomitant translocation of TLR signalling components. A key intermediate in TLR1/2/4 signalling is TRAF6 and immunoblotting of highly purified cellular extracts from LPS-stimulated macrophages revealed that TRAF6 was enriched in mitochondrial fractions ( Fig. 2a ). This recruitment was specific to TRAF6 because other cytosolic proteins that interact transiently with TLR signalling complexes, such as MyD88, IRAK4 (not shown), IRAK1, TAK1, and IkBa, were not detected in mitochondrial fractions. Furthermore, stimulation with Pam3CSK4 and LTA induced TRAF6 recruitment to mitochondria with similar kinetics to that triggered by LPS ( Fig. 2b) . Consistent with the results concerning mROS generation, we were unable to detect TRAF6 in the mitochondrial fractions of macrophages stimulated with poly(I:C) or CpG (Fig. 2c ).
The induction of mROS and the recruitment of TRAF6 to mitochondria upon TLR1/2/4 stimulation indicated that TRAF6 might interact with mitochondrial proteins to control mROS production. Recent studies have shown that ECSIT, a previously characterized TRAF6-interacting protein, localizes to mitochondria and has a role in oxidative phosphorylation complex I assembly 5, 20, 21 . Mass spectrometry analysis of purified ECSIT protein complexes confirmed that ECSIT associates with oxidative phosphorylation complex I components (Supplementary Table 1 ). Immunofluorescence microscopy and biochemical fractionation experiments revealed that ECSIT localizes predominantly to mitochondria in both fibroblasts and BMDMs ( Supplementary Fig. 3a -c). Additional analysis confirmed that ECSIT localizes to the inner mitochondrial membrane, consistent with its role in complex I assembly 5 . However, we also observed some ECSIT molecules proximal to outer mitochondrial membranes (OMMs), indicating that OMM-associated ECSIT might interact with TRAF6 recruited from phagosomal TLR signalling complexes ( Supplementary Fig. 3d-f ). Accordingly, we detected inducible interactions between ECSIT and TRAF6 in purified mitochondrial extracts from macrophages stimulated with LPS ( Fig. 2d ).
TRAF6 possesses E3-ubiquitin ligase activity; therefore, we explored whether ECSIT is ubiquitinated by TRAF6 (ref 22, 23) . ECSIT was polyubiquitinated when co-transfected with TRAF6 in HEK 293 cells ( Supplementary Fig. 4a ) and a dominant-negative form of ECSIT lacking the TRAF6 interaction domain was significantly less ubiquitinated by TRAF6 than wild-type ECSIT ( Supplementary Fig. 4b ) 21 . We also detected an increase in ECSIT polyubiquitination in macrophages after exposure to LPS, which mirrored the mitochondrial recruitment kinetics of TRAF6 ( Supplementary Fig. 4c ). In addition, total LPSinduced ECSIT ubiquitination was decreased in TRAF6-knockdown macrophages, indicating a requirement for TRAF6 in the ubiquitination of ECSIT during TLR4 signalling ( Supplementary Fig. 4c ).
We next investigated the dynamics of ECSIT localization in mitochondria after LPS stimulation. Notably, after 30 min of LPS treatment, ECSIT became more sensitive to proteinase K in the absence of OMM permeabilization by saponin ( Fig. 2e ). In contrast, the inner mitochondrial membrane protein NDUFS3 remained largely insensitive to proteinase K without saponin treatment. This indicates that ECSIT becomes enriched at the mitochondrial periphery, and thus becomes more sensitive to protease digestion, upon LPS signalling. Electron microscopy analysis further confirmed these data, as more ECSIT was localized peripheral to the OMM after LPS treatment (Supplementary Fig. 5 ). Protease sensitivity assays on mitochondria from TRAF6-knockdown RAW cells indicated that TRAF6 is required for LPS-induced ECSIT enrichment on OMMs ( Supplementary Fig. 6 , compare lanes 5 and 7 with 9 and 11). In addition to influencing the mitochondrial localization of ECSIT, TRAF6-ECSIT signalling also appears to regulate the recruitment of mitochondria around PAMPcoated latex beads. Both TRAF6-knockout and ECSIT-knockdown BMDMs showed less mitochondrial enrichment around phagosomes containing LPS-and Pam3CSK4-coated beads than did wild-type BMDMs ( Supplementary Fig. 7 ).
The link between ECSIT and complex I led us to hypothesize that ECSIT might modulate mROS derived from this complex 5, 7 . To a-e, RAW cells were stimulated with TLR agonists for the indicated times, cells were fractionated and extracts were western-blotted. cyt., cytoplasmic localization; p.m./endos., plasma membrane/endosomes localization; mito., mitochondrial localization. d, Purified mitochondrial lysates were immunoprecipitated with ECSIT antibody overnight. e, Equal amounts of extracts were treated with the indicated amount of proteinase K (13, 33 ng ml 21 ; 0.13, 3.3 ng ml 21 ) on ice with or without 0.2% saponin to permeabilize mitochondrial membranes.
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establish the role of ECSIT in TLR1/2/4-dependent upregulation of mROS, we sought to examine macrophages lacking ECSIT. Although Ecsit-knockout mice have been generated, they are very early embryonic lethals 24 . Heterozygous Ecsit 1/2 animals are viable but have ,40% less ECSIT than wild-type animals ( Supplementary Fig. 8a ). Interestingly, BMDMs from Ecsit 1/2 mice generated modestly lower mROS and cellular H 2 O 2 when stimulated with LPS and LTA (Supplementary Fig. 8b, c) . To confirm the importance of TLR1/2/4induced TRAF6-ECSIT signalling in mROS responses, we analysed Traf6-and Ecsit-knockdown BMDMs ( Fig. 3a and Supplementary  Fig. 11a ). Upon LPS (Fig. 3b ) or LTA ( Supplementary Fig. 9 ) stimulation, we observed marked reductions in mROS production in both ECSIT-and TRAF6-depleted macrophages at all time points tested. Although TLR-generated mROS responses were impaired in Ecsitknockdown cells, mROS production elicited by rotenone or antimycin 
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A was unaffected ( Supplementary Fig. 10 ). In addition, LPS-( Fig. 3c and Supplementary Fig. 11b ), LTA-( Supplementary Fig. 9 ) and Pam3CSK4-induced ( Supplementary Fig. 11c ) cellular H 2 O 2 levels were markedly reduced upon Ecsit and Traf6 knockdown. Thus, induction of mROS and cellular H 2 O 2 by bacterial PAMPs is critically dependent on both TRAF6 and ECSIT. To determine whether the E3-ubiquitin ligase activity of TRAF6 is required for ROS generation, we examined Traf6-knockout BMDMs reconstituted with either wildtype or RING (really interesting new gene) finger domain mutant Traf6 constructs (Fig. 3d) 25 . In agreement with the knockdown results, TRAF6-null BMDMs generated markedly lower levels of mROS and cellular H 2 O 2 in response to both LPS and LTA (Fig. 3e, f) . Null macrophages reconstituted with wild-type, but not RING mutant, TRAF6 regained the ability to generate ROS in response to TLR2/4 agonists (Fig. 3e, f) . Therefore, these data indicate that a functional RING domain is required for TRAF6 signalling to induce ROS generation, probably because TRAF6 mediates ECSIT ubiquitination (Supplementary Fig. 4) .
To test the functional significance of these findings, we assessed the responses of ECSIT-and TRAF6-deficient macrophages to Salmonella typhimurium, a Gram-negative, facultative intracellular pathogen that is sensitive to ROS-dependent killing [26] [27] [28] . Consistent with the results obtained using purified PAMPs, we observed decreased mitochondrial and cellular ROS in Ecsit-and Traf6-knockdown BMDMs when exposed to S. typhimurium ( Supplementary Fig. 12 ). To determine whether mROS are important in macrophage bactericidal responses, control or Ecsit-knockdown BMDMs were infected with GFP-expressing S. typhimurium and analysed by immunofluorescence microscopy and western blotting. Notably, ECSIT-depleted BMDMs harboured significantly more GFP-expressing S. typimurium than control cells (Fig. 4a, b) . The direct measurement of intracellular bacterial colony forming units showed that there were significantly more bacteria in ECSIT-deficient cells than in control cells at all time points examined (Fig. 4c ). The reduced ability of ECSIT-deficient BMDMs to control intracellular bacteria was not the result of a non specific impairment of NADPH-oxidase activity, as the PMA-stimulated respiratory burst was unaffected in Ecsit knockdowns ( Supplementary  Fig. 13 ). Additionally, nitric oxide and proinflammatory cytokine production were similar in control and knockdown BMDMs, collectively indicating that ECSIT depletion does not result in systemic innate immune deficiency ( Supplementary Fig. 14) .
Mitochondria are regarded as a significant source of H 2 O 2 in most cell types and peroxisomal catalase converts H 2 O 2 into water and oxygen, reducing oxidative damage caused by these ROS 7 . Overexpressing catalase in mitochondria using transgenic approaches (MCAT mice) leads to significantly lower mitochondrial H 2 O 2 levels and these transgenic mice show lower levels of age-related oxidative damage and an extended lifespan 29 . Consistent with our finding that mROS contribute to total cellular ROS levels, MCAT BMDMs generated significantly less LPS-induced cellular H 2 O 2 than wild-type cells (Supplementary Fig. 15 ). To test the specific role of H 2 O 2 derived from mitochondria in controlling intracellular bacterial replication, wildtype or MCAT BMDMs were challenged with GFP-expressing S. typhimurium. Similar to Ecsit knockdowns, MCAT BMDMs had significantly higher bacterial loads than wild-type cells between 8 and 24 h after infection (Fig. 4d, e ). Finally, to confirm the role of mROS in control of bacterial infection in vivo, we challenged wild-type, MCAT and Ecsit 1/2 mice by intraperitoneal infection with S. typhimurium and measured bacterial burdens in the spleen and liver five days after infection. In agreement with data from isolated BMDMs, both MCAT and Ecsit 1/2 mice harboured roughly twofold to three fold more bacteria per gram of tissue than wild-type littermates, further substantiating the notion that mROS play an integral part in antibacterial innate immunity (Fig. 4f, g) .
We have discovered a novel pathway by which macrophages generate ROS in response to bacteria by coupling TLR1/2/4 signalling to mitochondrial complex I via TRAF6 and ECSIT ( Supplementary  Fig. 1 ). Our study demonstrates that in addition to NADPH-oxidasederived ROS, mROS have an important role in macrophage innate immunity. To our knowledge, this is the first evidence of direct communication between TLRs and mitochondria. This study also highlights a remarkable symmetry between mitochondrial antiviral signalling protein (MAVS) and ECSIT in innate immune responses. As the clearance of intracellular bacteria requires ROS, TRAF6-ECSIT signalling is engaged downstream of bacterial PAMP-sensing TLRs for robust ROS production; likewise, MAVS signalling is activated by virussensing RIG-I-like (also known as DDX58) receptors to induce type I interferon production and effective antiviral immunity. Our current findings further solidify the emerging idea that mitochondria serve as hubs for innate immune signalling and the generation of effector responses.
METHODS SUMMARY
Animal strains. Ecsit-heterozygous and MCAT mice were previously described and maintained on a C57BL/6 background 24, 29 . ROS measurements. Cells were incubated with MitoSOX (to measure the mROS superoxide) and/or CM-H 2 DCFDA (to measure total cellular H 2 O 2 ) (Invitrogen) at 2.5 mM final concentration. Unstained controls were treated similarly, except that treatments and dyes were omitted. Cellular fractionation and mitochondrial isolation. Cell pellets were swelled on ice for 10 min, homogenized with a motorized Teflon pestle, then 2.53 MS buffer (525 mM mannitol, 175 mM sucrose, 12.5 mM Tris-HCl, pH 7.5, 12.5 mM EDTA) was added to 13 final buffer concentration. The homogenate was centrifuged three times at 980g for 10 min to pellet nuclei. The supernatant was transferred to a fresh tube and spun at 17,000g for 30 min to pellet mitochondria and the resulting cytosolic supernatant was saved for further analysis. The mitochondrial pellet was washed three times with 13 MS buffer, re-suspended in Sucrose-TE (20% sucrose, 50 mM Tris-HCl, pH 7.5, 10 mM EDTA) and then purified additionally by centrifugation through a 1.0-1.5 M sucrose step gradient at 100,000g for 60 min. Highly purified heavy mitochondria were removed from the interface of the two sucrose solutions by pipetting and transferred to a fresh tube. Mitochondria were then washed three times with 1 ml of 13 MS buffer and pelleted by centrifugation at 13,000 r.p.m. for 10 min. Bacterial challenge. Gentamicin protection assays were performed using S. typhimurium SL1344 transformed with a GFP expression plasmid essentially as described 30 . In vivo challenges were performed by intraperitoneally injecting S. typhimurium SL1344 bacteria in 100 ml PBS. Five days after infection, mice were killed, livers and spleens were isolated and tissues were weighed and homogenized in PBS.
METHODS
Animal strains. Ecsit heterozygous and MCAT mice were previously described and maintained on a C57BL/6 background 24, 29 . Cell lines and reagents. RAW 264.7, J774A.1 and NOR10 cells were obtained from the ATCC and maintained in DMEM (Invitrogen) containing 5% fetal bovine serum (FBS) (Atlanta Biological). Escherichia coli LPS (L6529) and all other chemicals were obtained from Sigma unless otherwise noted. TNF-a was from R&D Systems. CpG 1826 oligonucleotides were synthesized by IDT. Staphylococcus aureus LTA, R848 and Pam3CSK4 were purchased from Invivogen. Rabbit polyclonal antibodies against ECSIT were previously described 24 . The following antibodies were also used: mouse monoclonal NDUFS3, VDAC, GRIM19, cytochrome c (Mitosciences); goat polyclonal HSP60 and HSP70, rabbit polyclonal IRAK1 and IkBa, mouse monoclonal ubiquitin (Santa Cruz Biotechnology); mouse monoclonal COX1 (Molecular Probes); mouse monoclonal catalase, b-tubulin, Flag M2, HA (Sigma); rabbit monoclonal TRAF6 (Abcam); rabbit polyclonal MAVS and TAK1 (Cell Signaling Technology); mouse monoclonal Dab2 and GFP (BD Biosciences). ROS measurements. Cells (RAW or BMDMS) were plated in non-tissue-culturetreated six-well dishes and treated with various agonists or stimulated with TLR ligands as indicated. Concentrations of stimulants were as follows: 500 ng ml 21 LPS, 1 mg ml 21 Pam3CSK4, 2 mg ml 21 LTA, 10 mg ml 21 poly(I:C), 1 mM CpG, 1 mg ml 21 R848, 10 ng ml 21 TNF-a, 500 nM rotenone, or 5 mM antimycin A. Culture medium was removed, cells were washed with PBS, then incubated with MitoSOX (to measure the mROS superoxide) and/or CM-H 2 DCFDA (to measure total cellular H 2 O 2 ) (Invitrogen) at 2.5 mM final concentration in serum-free DMEM (Invitrogen) for 15 to 30 min at 37 uC. Cells were washed with warmed PBS (37 uC), removed from plates with cold PBS containing 1 mM EDTA by pipetting, pelleted at 1,500 r.p.m. for 3 min, immediately re-suspended in cold PBS containing 1% FBS and subjected to fluorescence-activated cell sorting (FACS) analysis. Unstained controls were treated similarly, except that treatments and dyes were omitted. To control for baseline dye fluorescence, samples from each experiment were left unstimulated but stained according to the above procedure. Microparticles were added at a concentration of approximately 4-8 beads per cell and allowed to settle on the cells for an additional 10 min on ice. Warm medium was added to the cells and plates were moved to 37 uC to allow bead phagocytosis for the indicated times. Cells were then fixed for 20 min at room temperature with paraformaldehyde, permeabilized with 0.1% Triton X-100 and stained with the indicated primary and appropriately labelled secondary antibodies for confocal microscopy. Co-localization and quantification analysis was performed using ImageJ software. Three large fields of view were collected for each condition (each field of view contained roughly 30 cells and approximately 120 yellow orange beads) and the integrated density of the colocalized beads (red pixels) and mitochondria (green pixels) was determined for each image. This value was divided by the total number of beads in each field to determine colocalized pixels per bead and the mean and s.d. were calculated by averaging the three fields of view for each condition. The percentage of beads with mitochondrial cupping (defined as colocalized mitochondria surrounding ,20% or more of the bead periphery) was determined by analysing the same fields of view described above and calculating the mean and s.d. of the percentage values obtained. Cellular fractionation and mitochondrial isolation. PBS-washed cell pellets were re-suspended in ten pellet volumes of RSB buffer (10 mM NaCl, 1.5 mM CaCl 2 , 10 mM Tris-HCl, pH 7.5), swelled on ice for 10 min, homogenized with a motorized Teflon pestle, then 2.53 MS buffer (525 mM mannitol, 175 mM sucrose, 12.5 mM Tris-HCl, pH 7.5, 12.5 mM EDTA) was added to 13 final buffer concentration. The homogenate was centrifuged three times at 980g for 10 min to pellet nuclei, which were saved for western blot analysis. The supernatant was transferred to a fresh tube and spun at 17,000g for 30 min to pellet mitochondria and the resulting cytosolic supernatant was saved for further analysis. The mitochondrial pellet was washed three times with 13 MS buffer, re-suspended in Sucrose-TE (20% sucrose, 50 mM Tris-HCl, pH 7.5, 10 mM EDTA), then purified additionally by centrifugation through a 1.0-1.5 M sucrose step gradient at 100,000g for 60 min. Highly purified heavy mitochondria were removed from the interface of the two sucrose solutions by pipetting and were then transferred to a fresh tube. Mitochondria were washed three times with 1 ml of 13 MS buffer and pelleted by centrifugation at 13,000 r.p.m. for 10 min. SDS was then added to nuclear and cytosolic fractions to a final concentration of 1% and mitochondrial pellets were re-suspended in SDS lysis buffer (20 mM Tris-HCl, 1% SDS, pH 7.5) and boiled for 5 min before normalizing protein concentration and western blotting. Fraction purity was confirmed by blotting for IkBa and tubulin (cytoplasm, cyto.), Dab2 (plasma membrane and endosomes, p.m./endos.), and GRIM19 and VDAC (mitochondria, mito.). Mitochondrial sub-fractionation and Triton X-100 extraction. RAW cell mitochondria were highly purified as above and sub-fractionated as described 31 . For Triton X-100 solubility assay, equal amounts of RAW mitochondria were resuspended in 13 MS buffer containing the indicated concentrations of Triton X-100 on ice for 20 min. The samples were then spun at 8,000g to separate unsolubilized mitochondria from extracted proteins in the supernatant and the resulting pellets were completely solubilized in 1% Triton X-100. Triton concentrations between 0.01% and 0.05% solubilize outer mitochondrial membrane and intermembrane space proteins, whereas concentrations above 0.1% solubilize both outer and inner membrane proteins. Samples were then blotted accordingly. TRAF6 recruitment and protease sensitivity assays. For the TRAF6 recruitment assay, RAW cells were left untreated or stimulated with TLR agonists (1 mg ml 21 LPS, 1 mg ml 21 Pam3CSK4, 2 mg ml 21 LTA, 1 mM CpG, or 10 mg ml 21 poly(I:C)), subjected to mitochondrial isolation as above and fractions were blotted as indicated. For mito-immunoprecipitation, mitochondria were lysed in TNT buffer (25 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM EDTA, protease/phosphatase inhibitors) and incubated with ECSIT antibody and anti-rabbit IgG agarose overnight at 4 uC. The samples were washed extensively and blotted. For the proteinase K sensitivity assay, RAW cells treated with a control shRNA to GFP or with Traf6 shRNA were left untreated or stimulated with LPS, subjected to mitochondrial fractionation, then purified mitochondria were re-suspended in digest buffer (25 mM Tris-HCl, pH 7.5, 125 mM sucrose, 1 mM CaCl 2 ). Samples were incubated with proteinase K (13, 33 ng ml 21 ; 0.13, 3.3 ng ml 21 ; 11, 12 ng ml 21 ; 1, 6 ng ml 21 ) with or without 0.1% saponin on ice for 30 min. Saponin was used to permeabilize mitochondrial membranes gently and allow proteinase K to enter mitochondria. Proteinase K activity was quenched with phenylmethylsulphonyl fluoride (PMSF), SDS was added to 1% to solubilize mitochondrial proteins and samples were blotted as indicated. Ubiquitination assays. For endogenous ubiquitination assays, one 10-cm dish of J774 control GFP shRNA or Traf6 shRNA cells per time point was stimulated as described and solubilized in boiling SDS lysis buffer, then boiled for an additional 10 min. After shearing DNA, the samples were diluted in 23 TNT buffer to 13 and immunoprecipitated overnight with ECSIT antibody and anti-rabbit IgG beads (eBioscience). Beads were washed in 13 TNT buffer and samples were blotted and probed with antibodies as indicated. All other ubiquitination assays were performed using 6-cm dishes of 293T cells transfected with 0.25-1 mg each of the indicated constructs. After overnight incubation (and 2 h incubation in MG132, if indicated), cells were lysed as described above, diluted in 23 TNT buffer and immunoprecipitated with anti-Flag resin (Sigma) overnight. Beads were washed extensively and samples blotted and probed as indicated. TRAF6, ECSIT-FLAG, and DN-ECSIT-Flag were previously described 21 . Bacterial infection and gentamicin protection assay. Gentamicin protection assays were performed using S. typhimurium SL1344 32 transformed with a GFP expression plasmid essentially as described 30, 33 . Briefly, BMDMs were plated at 2 3 10 5 cells per well in 24-well dishes, incubated with opsonized (using fresh mouse serum) GFP-expressing Salmonella at a multiplicity of infection of 20 for 1 h, then further incubated with 100 mg ml 21 gentamicin for 1 h. Wells were washed several times and 2 h time points were collected or cells further incubated in media containing 10 mg ml 21 gentamicin. Similar results were obtained when the initial 100 mg ml 21 gentamicin incubation was omitted and cells were only exposed to 10 mg ml 21 gentamicin (not shown). For colony count analysis, triplicate samples were lysed in PBS containing 1% Triton X-100, serially diluted in PBS and plated on LB agar plates containing streptomycin. For western blot analysis of GFP-expressing Salmonella, triplicate BMDMs samples were infected as above and cells were lysed at indicated time points in SDS lysis buffer. After boiling and shearing DNA, samples were pooled and blotted as described. For immunofluorescence analysis of GFP-expressing Salmonella, 23 10 5 BMDMs were grown on coverslips in 12-well dishes and treated as above. At indicated time points, cells were fixed with 4% paraformaldehyde for 20 min at room temperature, nuclei stained with DAPI and cells mounted and imaged by confocal microscopy. Experiments shown are representative of at least three independent experiments. In vivo Salmonella infection assay. 8-10-week-old wild-type, MCAT, or Ecsit 1/2 littermates were injected intraperitoneally with 200 S. typhimurium SL1344 bacteria in 100 ml PBS. Five days after infection, mice were killed, livers and spleens were isolated and tissues were weighed and homogenized in 1 ml PBS.
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